Tony Butler
Stock Analyst at Rodman & Renshaw
(0.76)
# 3,934
Out of 4,964 analysts
105
Total ratings
32.35%
Success rate
-13.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $12.35 | +102.43% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.90 | +279.31% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.86 | +867.74% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.07 | +624.64% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.29 | +2,651.98% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.52 | +3,006.19% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.06 | +16,650.42% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.12 | +792.86% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $53.53 | +40.11% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $67.27 | -47.97% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $1.12 | +5,257.14% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.46 | +793.47% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.99 | +615.31% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.16 | +1,193.10% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.45 | +5,495.34% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.36 | +1,002.94% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $13.04 | -23.31% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.87 | +492.33% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.54 | +3,556.39% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.53 | +984.99% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.28 | +10,426.32% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.67 | +800.63% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $6.02 | +5,880.07% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.48 | -42.53% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.80 | +294.74% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $0.94 | +963.94% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.28 | +357.32% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $11.42 | +863.22% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $5.18 | +18,432.82% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $12.35
Upside: +102.43%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.90
Upside: +279.31%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.86
Upside: +867.74%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.07
Upside: +624.64%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.29
Upside: +2,651.98%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.52
Upside: +3,006.19%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.06
Upside: +16,650.42%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.12
Upside: +792.86%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $53.53
Upside: +40.11%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $67.27
Upside: -47.97%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $1.12
Upside: +5,257.14%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.46
Upside: +793.47%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $6.99
Upside: +615.31%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.16
Upside: +1,193.10%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.45
Upside: +5,495.34%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.36
Upside: +1,002.94%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $13.04
Upside: -23.31%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $2.87
Upside: +492.33%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.54
Upside: +3,556.39%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $5.53
Upside: +984.99%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.28
Upside: +10,426.32%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.67
Upside: +800.63%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $6.02
Upside: +5,880.07%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.48
Upside: -42.53%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.80
Upside: +294.74%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $0.94
Upside: +963.94%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $3.28
Upside: +357.32%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $11.42
Upside: +863.22%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $5.18
Upside: +18,432.82%